Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells. - Wikidata - awgldk - TriplyDB

Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.

Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.

http://www.wikidata.org/entity/Q39138372

about

Overexpression of lipocalins and pro-inflammatory chemokines and altered methylation of PTGS2 and APC2 in oral squamous cell carcinomas induced in rats by 4-nitroquinoline-1-oxide A role for novel adipose tissue-secreted factors in obesity-related carcinogenesis.Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer.Involvement of the carboxyl-terminal region of the yeast peroxisomal half ABC transporter Pxa2p in its interaction with Pxa1p and in transporter function.Epigenetic induction of epithelial to mesenchymal transition by LCN2 mediates metastasis and tumorigenesis, which is abrogated by NF-κB inhibitor BRM270 in a xenograft model of lung adenocarcinoma.Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer.Down-regulation of neutrophil gelatinase-associated lipocalin in head and neck squamous cell carcinoma correlated with tumorigenesis, not with metastasis.Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells.Overexpression of lipocalin 2 in human cervical cancer enhances tumor invasion.Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition.Neutrophil gelatinase-associated lipocalin as a screening test in prostate cancer.Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.Overexpression of HepaCAM inhibits cell viability and motility through suppressing nucleus translocation of androgen receptor and ERK signaling in prostate cancer.Licochalcone A suppresses migration and invasion of human hepatocellular carcinoma cells through downregulation of MKK4/JNK via NF-κB mediated urokinase plasminogen activator expression.Lipocalin 2 negatively regulates cell proliferation and epithelial to mesenchymal transition through changing metabolic gene expression in colorectal cancer.Metastasis tumor-associated protein-2 knockdown suppresses the proliferation and invasion of human glioma cells in vitro and in vivo.N-Glycosylation of Lipocalin 2 Is Not Required for Secretion or Exosome Targeting.Alterations in Cellular Iron Metabolism Provide More Therapeutic Opportunities for Cancer.Overexpression of homeodomain-interacting protein kinase 2 (HIPK2) attenuates sepsis-mediated liver injury by restoring autophagy

P2860

Q28543174-031D6481-6AD9-4E3B-AD2D-E972796194E3 Q30384899-6E622F8F-8202-44CC-AB88-145A7602C902 Q33688934-A0719319-6A1F-418C-A325-59DE2B5719BB Q35223932-3B881691-A820-43F7-ACC2-99E7E60AF3F2 Q35843206-6B8E4A0F-9B0F-4778-AAAC-08CE8464A29C Q36020915-3507DE84-9875-406C-A137-0CC8C4F2EC27 Q36095074-91A0FE34-456D-447F-A5EC-4C7742BBF085 Q36782414-D8AA069F-54F2-43C3-99B8-E4C9B97079B9 Q36998174-25D75546-0CE9-4457-A0CC-12BA379DC444 Q37470464-69912D6A-485D-4F50-9BF8-C84D82D3227A Q37671600-82DA170B-2749-4DEB-B48C-F7F9412B1F8C Q38954232-9A823736-69A9-4A48-8C9F-234EBB654953 Q38996973-3554510D-1B3D-4DC4-B0DD-DD55BCD7CC55 Q39030249-FED06F41-2972-4FD5-AB6C-7910175A4377 Q45894433-A24653BD-A5A5-4537-AC9C-20EF1368B1F0 Q48645806-1F72192E-D352-4616-83CE-BA3C201AAC42 Q55080780-13BB7FBD-7128-4D30-A2F5-3BBF242DADE1 Q55497286-F072DD70-4DB2-4A27-8C29-CF57994BF97E Q58699616-1B66BCB5-6934-40E8-967E-535656558CC9

P2860

Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.

http://www.wikidata.org/entity/Q39138372

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.

@en

Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.

@nl

type

label

Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.

@en

Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.

@nl

prefLabel

Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.

@en

Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.

@nl

P1433

Q39138372-331B726E-19E3-4F07-A31A-94001EF67B04

P1476

Q39138372-1B453186-5CB8-497C-AD8B-7072792C547A

P2093

Q39138372-14754279-299A-4DE5-9310-E1A3EC82419D

Q39138372-300C39AB-8546-41F1-AD0E-4D8F850C8382

Q39138372-79FC5F90-6720-40DF-9FBE-22CEB193979D

Q39138372-8AA11467-D5D7-49CF-91BC-16035610DADF

Q39138372-948FD83A-10D1-4C73-833E-74815B365485

Q39138372-98D7CB93-B272-48B1-81CF-326BA2AFB719

Q39138372-B5B737A4-220B-432E-8E18-96798C091CD6

Q39138372-C020BEEF-34C8-490F-9476-27FEEE2AB8BF

P2860

Q39138372-00A60797-E9B0-45DF-82D1-278BDF51BD81

Q39138372-047156A4-CFDA-4709-9F93-58E88DDE7283

Q39138372-0AA55534-D41F-444F-ABB6-617FB5B749BB

Q39138372-14D2393F-3FE1-4DC5-A6A5-B97E39314D51

Q39138372-301B253D-7AE4-4B13-9F75-C04F94A6125F

Q39138372-3C2A7CBD-F01F-4D11-9B1E-A9E501BBB7C4

Q39138372-44764F09-CD5D-43A5-8EB2-B70825F0221E

Q39138372-47EDC432-2D5D-4915-90E4-D0A32B30A43B

Q39138372-507DED34-9188-489E-A941-851795D45543

Q39138372-50D23519-A748-4F5B-B343-565AA15E6F95

P304

Q39138372-5B397B30-DE03-4066-87FA-EC814C23F814

P31

Q39138372-70B609A9-688B-4C6C-9F39-1BC4E81AF00E

P356

Q39138372-43586421-C995-458E-BF86-E1AFB3B97298

P433

Q39138372-CB299902-FD2A-4635-95EB-3775C59AEB5E

P478

Q39138372-E93C9D00-2DA1-4212-A828-46EBD708CD31

P577

Q39138372-DFB41659-7BF3-4E1E-9D18-BA7C27F57920

P698

Q39138372-7375FA9A-4164-4A6A-B202-8DFD6AFAB0FE

P356

P1433

P1476

Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.

@en

P2093

Chun-Wen Cheng

http://www.w3.org/2001/XMLSchema#string

Min-Che Tung

http://www.w3.org/2001/XMLSchema#string

Min-Hsien Huang

http://www.w3.org/2001/XMLSchema#string

Rong-Tzong Tsai

http://www.w3.org/2001/XMLSchema#string

Shao-Chuan Wang

http://www.w3.org/2001/XMLSchema#string

Shu-Ching Hsieh

http://www.w3.org/2001/XMLSchema#string

Shun-Fa Yang

http://www.w3.org/2001/XMLSchema#string

Yi-Hsien Hsieh

http://www.w3.org/2001/XMLSchema#string

P2860

CDK inhibitors: positive and negative regulators of G1-phase progression

Lipocalin2 promotes invasion, tumorigenicity and gemcitabine resistance in pancreatic ductal adenocarcinoma

A gene transcription signature associated with hormone independence in a subset of both breast and prostate cancers

Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis.

GLI1 confers profound phenotypic changes upon LNCaP prostate cancer cells that include the acquisition of a hormone independent state

ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent manner.

Interstitial guidance of cancer invasion.

Lipocalin 2 expression is associated with aggressive features of endometrial cancer.

Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia.

Tissue involution and the acute phase response.

P304

1281-1290

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.22670

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23775308

http://www.w3.org/2001/XMLSchema#string